147 related articles for article (PubMed ID: 7113899)
1. Beneficial hemodynamic effects of intravenous diazoxide in refractory congestive heart failure.
Massie BM; Stern R; Hanlon JT; Haughom F
Am Heart J; 1982 Sep; 104(3):581-6. PubMed ID: 7113899
[TBL] [Abstract][Full Text] [Related]
2. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
Maskin CS; Sinoway L; Chadwick B; Sonnenblick EH; Le Jemtel TH
Circulation; 1983 May; 67(5):1065-70. PubMed ID: 6831672
[TBL] [Abstract][Full Text] [Related]
3. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
Kubo SH; Fox SC; Prida XE; Cody RJ
Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315
[TBL] [Abstract][Full Text] [Related]
4. Acute hemodynamic effects of endralazine: a new vasodilator for chronic refractory congestive heart failure.
Quyyumi AA; Wagstaff D; Evans TR
Am J Cardiol; 1983 May; 51(8):1353-7. PubMed ID: 6846162
[TBL] [Abstract][Full Text] [Related]
5. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R
J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure.
Elkayam U; Weber L; McKay C; Rahimtoola S
Am J Cardiol; 1985 Sep; 56(8):560-6. PubMed ID: 4036843
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
[TBL] [Abstract][Full Text] [Related]
8. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.
Elkayam U; Weber L; McKay CR; Rahimtoola SH
Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802
[TBL] [Abstract][Full Text] [Related]
9. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic action of nicorandil in chronic congestive heart failure.
Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R
Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325
[TBL] [Abstract][Full Text] [Related]
11. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
Amin DK; Shah PK; Shellock FG; Hulse S; Brandon G; Spangenberg R; Swan HJ
Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585
[TBL] [Abstract][Full Text] [Related]
12. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.
Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R
Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
Awan NA; Evenson MK; Needham KE; Evans TO; Hermanovich J; Taylor CR; Amsterdam E; Mason DT
Circulation; 1981 Jan; 63(1):96-101. PubMed ID: 7438412
[TBL] [Abstract][Full Text] [Related]
14. Association between exogenous atrial natriuretic peptide and hemodynamics in dogs with congestive heart failure produced by experimental mitral regurgitation.
Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T
J Vet Med Sci; 2001 Mar; 63(3):243-50. PubMed ID: 11307923
[TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
Olivari MT; Levine TB; Cohn JN
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
[TBL] [Abstract][Full Text] [Related]
16. Minoxidil therapy in chronic congestive heart failure: acute plus long-term hemodynamic and clinical study.
McKay CR; Chatterjee K; Ports TA; Holly AN; Parmley WW
Am Heart J; 1982 Sep; 104(3):575-80. PubMed ID: 7113898
[TBL] [Abstract][Full Text] [Related]
17. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M
Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
[TBL] [Abstract][Full Text] [Related]
18. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure.
Packer M; Medina N; Yushak M
Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
Rude RE; Turi Z; Brown EJ; Lorell BH; Colucci WS; Mudge GH; Taylor CR; Grossman W
Circulation; 1981 Jul; 64(1):139-45. PubMed ID: 7237712
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]